However, in regard to antioxidant activity, a study by Tang et al. [38] (3500 m; 24 h) showed that 261 subjects had decreased SOD activity in plasma, suggesting that the decreased SOD activity was correlated with AMS severity. The gene discussed is SOD1; the disease is ablepharon macrostomia syndrome.